SCD catalyses the rate-limiting step in the production
of mono-unsaturated FAs and its expression and activity
has been linked to increased adiposity and insulin
insensitivity [34], which is a hallmark of the metabolic
syndrome and associated with an increased incidence of
cardiovascular disease, diabetes and cancer